The DOI matches its Crossref record.
A Thrombin‐Activated Peptide‐Templated Nanozyme for Remedying Ischemic Stroke via Thrombolytic and Neuroprotective Actions
Open accessAbstract
Ischemic stroke (IS) is one of the most common causes of disability and death. Thrombolysis and neuroprotection are two current major therapeutic strategies to overcome ischemic and reperfusion damage. In this work, a novel peptide‐templated manganese dioxide nanozyme (PNzyme/MnO 2 ) is designed that integrates the thrombolytic activity of functional peptides with the reactive oxygen species scavenging ability of nanozymes. Through self‐assembled polypeptides that contain multiple functional motifs, the novel peptide‐templated nanozyme is able to bind fibrin in the thrombus, cross the blood–brain barrier, and finally accumulate in the ischemic neuronal tissues, where the thrombolytic motif is “switched‐on” by the action of thrombin. In mice and rat IS models, the PNzyme/MnO 2 prolongs the blood‐circulation time and exhibits strong thrombolytic action, and reduces the ischemic damages in brain tissues. Moreover, this peptide‐templated nanozyme also effectively inhibits the activation of astrocytes and the secretion of proinflammatory cytokines. These data indicate that the rationally designed PNzyme/MnO 2 nanozyme exerts both thrombolytic and neuroprotective actions. Giving its long half‐life in the blood and ability to target brain thrombi, the biocompatible nanozyme may serve as a novel therapeutic agent to improve the efficacy and prevent secondary thrombosis during the treatment of IS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Xu, Y., Luo, Y., Weng, Z., Xu, H., Zhang, W., Li, Q., Liu, H., Liu, L., Wang, Y., Liu, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01940 · Cited by 393
Designing nanozymes for in vivo applications
Zhang, R., Jiang, B., Fan, K., Gao, L., & Yan, X. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00205-1 · Cited by 360
Self-citationBioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke
Liao, J., Li, Y., Fan, L., Sun, Y., Gu, Z., Xu, Q.-Q., Wang, Y., Xiong, L., Xiao, K., Chen, Z.-S., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c10982 · Cited by 104
The Role of the Complement System in Synaptic Pruning after Stroke
Liu, H., Jiang, M., Chen, Z., Li, C., Yin, X., Zhang, X., & Wu, M. (2024) · Aging and disease · doi:10.14336/ad.2024.0373 · Cited by 14
Metadata
- Authors
- Wang, Z., Zhao, Y., Hou, Y., Tang, G., Zhang, R., Yang, Y., Yan, X., & Fan, K.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2023-03-10
- Volume
- 36
- Issue
- 10
- Pages
- e2210144-e2210144
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W4318915168
- Cited by
- 205
- References
- 0
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Thrombin‐Activated Peptide‐Templated Nanozyme for Remedying Ischemic Stroke via Thrombolytic and Neuroprotective Actions. https://app.cochat.ai/papers/10.1002/adma.202210144
- The paper
- Wang, Z., Zhao, Y., Hou, Y., Tang, G., Zhang, R., Yang, Y., Yan, X., & Fan, K. (2024). A Thrombin‐Activated Peptide‐Templated Nanozyme for Remedying Ischemic Stroke via Thrombolytic and Neuroprotective Actions. Advanced Materials. https://doi.org/10.1002/adma.202210144
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.